<DOC>
	<DOCNO>NCT01823822</DOCNO>
	<brief_summary>This multicentre , randomise , double-blind , 2-parallel group , control trial aim investigate whether oral milk protein supplement lead increase serum Insulin-like Growth Factor-I level ( IGF-I ) compare control group feed iso-caloric supplement , woman anorexia nervosa . Subjects receive either 150g/day test product control product 4-week , follow 4-week follow-up .</brief_summary>
	<brief_title>Influence Protein Supplements Serum Insulin-like Growth Factor-I Levels Women With Anorexia Nervosa</brief_title>
	<detailed_description>Study centre : 4 active centre France 2 active centre Switzerland</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Women age 18 40 year ( bound include ) . Women serum IGFI level 25th percentile reference value accord age ( bound include ) . Women give write inform consent . Women DSMIVconfirmed anorexia nervosa last least 6 month . Women concomitant binge eat purge type also include . Women admit inhospital weight nutritional rehabilitation . It anticipate patient stay inhospital full duration 4week supplementation phase , least 5 week within study . Women already regular consumer dairy product . For woman childbearing potential , use contraceptive method . Discontinuation mineral vitamin supplement contain calcium vitamin D , 1 week start product consumption study . Women primary amenorrhea ; Women lactose intolerance ; Women metabolic disease could affect bone metabolism : osteogenesis imperfecta , Paget 's disease bone , hyperthyroidism , primary hyperparathyroidism ; Women current past neoplasm ; Women severe comorbidity ; Pregnant breast feed woman ; Women epilepsy ; Women current past use follow treatment : bisphosphonates , calcitonin , steroid ; Patients enrol another clinical study within last 4 week ; Patients already receive oral nutritional supplement need receive oral intravenous ( IV ) supplement followup ; Patients receive oral IV nutritional supplement within two week inclusion ; Patients will participate another clinical study present study phase 4 week end participation present study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Anorexia nervosa</keyword>
	<keyword>Protein supplement</keyword>
	<keyword>IGF-I</keyword>
</DOC>